International Stem Cell (ISCO) EPS (Basic) Growth (5y) (2015 - 2026)
International Stem Cell (ISCO) EPS (Basic) Growth (5y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 140.14 Bn | 132.29 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 87.02 Bn | 79.03 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.30 Bn | 60.12 Bn | 1.37 Bn |
| 4 | Moderna | 60.84 Bn | 55.70 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.15 Bn | 37.06 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.49 Bn | 28.18 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.78 Bn | 10.38 Bn | 668.28 Mn |
| 8 | Insmed | 27.55 Bn | 26.39 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.14 Bn | 26.31 Bn | - |
| 10 | International Stem Cell | 3.20 Mn | 2.11 Mn | 1.46 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 47.84% |
| Dec 31, 2025 | 24.14% |
| Sep 30, 2025 | 15.11% |
| Jun 30, 2025 | 20.95% |
| Mar 31, 2025 | -12.76% |
| Dec 31, 2024 | 14.92% |
| Sep 30, 2024 | -110.45% |
| Jun 30, 2024 | 15.89% |
| Mar 31, 2024 | 23.07% |
| Dec 31, 2023 | 24.07% |
| Sep 30, 2023 | -19.29% |
| Jun 30, 2023 | 17.94% |
| Mar 31, 2023 | 49.95% |
| Dec 31, 2022 | 15.55% |
| Sep 30, 2022 | 39.72% |
| Jun 30, 2022 | -14.89% |
| Mar 31, 2022 | 72.98% |
| Dec 31, 2021 | -15.63% |
| Sep 30, 2021 | -24.08% |
| Jun 30, 2021 | -15.22% |